Medindia

X

Nephrologists and Non-Nephrologists Alike Report Increased Attention on Chronic Kidney Disease

Friday, May 23, 2008 General News J E 4
Advertisement
EXTON, Pa., May 23 BioTrends Research Group, Inc. releaseda Special Report: "Referrals in Nephrology," providing insight into thereferral patterns and co-management of patients with Chronic Kidney Disease(pre-dialysis) from the perspective of Nephrologists, Cardiologists,Endocrinologists, and Primary Care Physicians. The newly released syndicatedreport offers a comprehensive view, based on qualitative interviews with 40physicians and quantitative feedback from close to 300 physicians, aboutawareness of CKD, triggers for referral, knowledge of and treatment withtherapies for renal anemia, secondary hyperparathyroidism, hyperphosphatemia,and hypertension. It also includes 10 interviews with Managed CareOrganizations to determine their involvement in referrals to Nephrologists andcontrol mechanisms for various classes and brands of medications.

According to the study, awareness of CKD seems to be growing among allspecialties. Although there is high agreement around the benefits of earlyscreening for CKD, there is relatively low familiarity with the NationalKidney Foundation's CKD Staging Classification and virtually no familiaritywith the Kidney Early Evaluation Program (KEEP), a program designed to raiseawareness, educate, provide physician referrals, and ultimately delay diseaseprogression. While Endocrinologists and Cardiologists do refer patients withCKD to Nephrologists, the majority of referrals come from PCPs. Managed caredoes not play a role in when patients are referred to Nephrologists.

In terms of treatment of CKD patients, while all specialties are familiarwith and comfortable prescribing ACEs and ARBs, there are differences betweenspecialties when it comes to phosphate binders, PTH modifiers, ESAs, and IVIron. Cardiologists are least interested in managing renal issues in patientswith CKD. Some of the differences in level of involvement are specialtydriven, whereas others seem to be based on practice setting(urban/rural/suburban) and practice type (solo/group/multi-specialty).Pharmaceutical companies appear to be taking different approaches to reachingthese non-Nephrology physicians involved in the management of CKD patients.Some companies are targeting them directly while others are limiting promotionto Nephrologists.

About BioTrends Research Group, Inc.

BioTrends Research Group, Inc. (www.bio-trends.com) provides syndicatedand custom market research to pharmaceutical manufacturers competing inclinically evolving, specialty pharmaceutical markets. For information onBioTrends publications and research capabilities, please contact JenniferRobinson at (610) 363-3872 or jrobinson@bio-trends.com.

All company, brand, or product names contained in this document may betrademarks of their respective holders.

SOURCE BioTrends Research Group, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Awareness of Genzyme's Renvela(R) (Sevelamer Carbo...
S
Cancer Survivors Develop Healthy Food Gift Busines...